Researchers at Phoenix’s Barrow Neurological Institute and the University of Pittsburgh have created a vast interactive atlas that may eventually help doctors use precision medicine to target treatments for traumatic brain injury (TBI) patients – and could replace the existing uniform treatment model.
Sarissa’s Alkermes board replacements largely fail to win support from shareholder firms, which cite Biogen board moves
Alex Denner, the investor behind the activist firm Sarissa Capital Management, is not winning much support for his board upheaval plans at Irish drugmaker Alkermes.